Hemodialysis for end-stage renal disease: A cost-effectiveness analysis of treatment options
- 1 January 2005
- journal article
- general essays
- Published by Cambridge University Press (CUP) in International Journal of Technology Assessment in Health Care
- Vol. 21 (1) , 32-39
Abstract
Background: During 2001, over 32,000 patients in the United Kingdom received renal replacement therapy (RRT). Approximately half had a functioning transplant, with the remainder receiving dialysis therapy. The main form of dialysis is hemodialysis (HD), which is provided to 37.1 percent of the RRT population. HD is provided in three main settings: hospital (24.5 percent), satellite (10.9 percent), or home (1.7 percent). The objective of this study is to explore the cost-effectiveness of these different modalities.Methods: By using clinical and cost data from a systematic review, a Markov model was developed to assess the costs and benefits of the three different modalities. The model included direct health service costs and quality-adjusted life years (QALYs). Sensitivity analyses were performed to assess the robustness of the results.Results: Satellite HD has lower costs £46,000 and £62,050 at 5 and 10 years than home HD £47,660 and £63,540. The total effectiveness of home HD was slightly greater than for satellite HD, so the incremental cost per QALY of home versus satellite HD was modest at £6,665 at 5 years and £3,943 at 10 years. Both modalities dominated hospital HD.Conclusions: Results from the study reveal that satellite HD was less costly than home HD, and home HD was less costly than hospital HD. The lack of robust data on the effectiveness and new dialysis equipment, which were not included in this review, throws some caution on these results. Nonetheless, the results are supportive of a shift from hospital HD to satellite and home HD.Keywords
This publication has 11 references indexed in Scilit:
- Systematic review of the effectiveness and cost-effectiveness, and economic evaluation, of home versus hospital or satellite unit haemodialysis for people with end-stage renal failureHealth Technology Assessment, 2003
- DIALYSIS FOR END-STAGE RENAL DISEASEInternational Journal of Technology Assessment in Health Care, 2001
- Home haemodialysis in the 1990sNephrology Dialysis Transplantation, 1998
- Economic evaluation of end stage renal disease treatmentHealth Policy, 1998
- The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions.Journal of Epidemiology and Community Health, 1998
- An Introduction to Markov Modelling for Economic EvaluationPharmacoEconomics, 1998
- Modeling Valuations for EuroQol Health StatesMedical Care, 1997
- Systematic Reviews: Checklists for review articlesBMJ, 1994
- The Science of Reviewing ResearchaAnnals of the New York Academy of Sciences, 1993
- Survival Rates of 2,728 Patients With End-Stage Renal DiseaseMayo Clinic Proceedings, 1984